Overview of the Market:
The Global Empty Capsules Market was worth $1685.2 million in 2019 and estimated to be growing at a CAGR of 7.57%, to reach $ 2428.6 million by 2024. The market is showcasing evident potential in the mentioned forecasting period. Empty Capsules are generally made from Gelatin, which is derived from plant or animal origin. These are used as dosage form for prescription and OTC drugs, nutrient supplements and herbal products.
Growth of global empty capsules market is expected to be driven by growing applications in pharmaceutical and nutraceuticals companies. Technological advancements coupled with growing consumer preference towards capsule based formulations are also fuelling the market growth. However increasing costs of raw material, stringent regulatory frameworks and religious issues concerned with the consumption of capsules containing animal derived ingredients are limiting the growth of the market.
Global Empty Capsules market is segmented by product, therapeutic application and End User. On the basis of product the market is further sub-segmented into Gelatin Capsules and Non-Gelatin Capsules. By therapeutic application global market for Empty capsules is segmented as Antibiotic and Antibacterial Drugs, Antacid and Antiflatulent Preparations, Anti anemic Preparations, Anti-Inflammatory Drugs, Cardiovascular Therapy Drugs, Dietary Supplements and Vitamins, Cough and Cold Preparations and other therapeutic applications. Based on End User the market is segmented as Pharmaceutical Industry, Cosmetics Industry, Nutraceutical Industry and Research Laboratories.
Gelatin Capsules is the largest product segment accounting for a share of approximately 80% whereas Non-Gelatin capsules is estimated to be the fastest segment with a CAGR of XX% due to increasing preference for vegetable origin capsules. Dietary supplements and vitamins segment is expected to be the fastest growing therapeutic application segment.
Geographical Analysis:
On the basis of geography global market for empty capsules is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the dominating market for Empty capsules accounting for a share of approximately 37% owing to rising consumer awareness and increase in the consumption of nutraceutical products. Asia-Pacific is estimated to be the fastest growing region due to increasing government support and increasing demand for nutraceuticals and cosmeceuticals.
Key Players in this Market:
Some of the major companies covered in the report are Capsugel, Acg Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co., Ltd. and Sunil Healthcare Limited
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Gelatin Capsules
5.1.2 Non Gelatin Capsules
5.2 By Therapeutic Applcation
5.2.1 Antibiotic and Antibacterial Drugs
5.2.2 Vitamins and Dietary Supplements
5.2.3 Antacid and Antiflatulent Preparations
5.2.4 Antianemic Preparations
5.2.5 Anti-Inflammatory Drugs
5.2.6 Cardiovascular Therapy Drugs
5.2.7 Cough and Cold Preparations
5.2.8 Other therapeutic applications
5.3 By End User
5.3.1 Pharmaceutical Industry
5.3.2 Nutraceutical Industry
5.3.3 Cosmetics Industry
5.3.4 Research Laboratories
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Capsugel
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Suheung Co Ltd.
8.3 Acg Worldwide
8.4 Bright Pharmacaps Inc.
8.5 Capscanada Corporation
8.6 Medi-Caps Ltd.
8.7 Qualicaps
8.8 Roxlor, LLC
8.9 Snail Pharma Industry Co., Ltd.
8.10 Sunil Healthcare Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
